Ruijin Hospital Hainan
Shanghai Jiao Tong University Affiliate · #1 in Lecheng Biomedical Technology Projects
Overview
Ruijin Hospital Hainan (Boao Research Hospital), affiliated with Shanghai Jiao Tong University School of Medicine, has the highest number of approved biomedical technology projects in Lecheng. It focuses on stem cell therapy, gene therapy, and immune cell therapy.
Ruijin Hospital is one of China's top hospitals with nationally leading endocrinology, respiratory, and hematology departments. The Hainan branch is the undisputed leader in respiratory stem cell therapy and iPSC therapy for neurodegenerative diseases.
Key Facts
All Approved Biomedical Technology Projects
Respiratory Stem Cell Therapy (Flagship)
China's undisputed leader in respiratory stem cell therapy — three airway basal stem cell technologies covering COPD, bronchiectasis, and ILD
Airway Basal Stem Cell Therapy for COPD
Autologous airway basal stem cells are extracted, expanded in vitro, and reinfused to repair damaged lung tissue. The world's leading airway regeneration technology and China's first approved respiratory stem cell therapy.
Airway Basal Stem Cell Therapy for Bronchiectasis
Targets recurrent infections and hemoptysis caused by structural bronchial damage. Autologous stem cells directionally repair the airway basement membrane.
Airway Basal Stem Cell Therapy for Interstitial Lung Disease
For IPF and other diffuse ILDs, autologous stem cell reinfusion slows fibrosis progression and improves lung diffusion function.
iPSC Therapy for Neurodegenerative Diseases (First in China)
Cutting-edge iPSC technology — China's first approved iPSC clinical program for neurodegenerative disease
iPSC-Derived Motor Neuron Progenitors for ALS
iPSCs are differentiated into motor neuron progenitor cells and transplanted to replace damaged motor neurons, slowing or even reversing disease progression. China's first approved iPSC clinical translation project.
Gene Therapy
RPE65 Gene Therapy for Inherited Retinal Dystrophy
AAV vector delivers the normal RPE65 gene to retinal pigment epithelial cells, restoring the visual cycle. Single-eye injection significantly improves vision.
Gene-Edited Autologous HSCT for Transfusion-Dependent β-Thalassemia
CRISPR gene editing repairs the BCL11A enhancer in autologous HSCs, activating fetal hemoglobin expression and eliminating transfusion dependence. Ages 7-55.
Metabolic Disease & Osteoarthritis
GLP1+FGF21 Dual-Factor Adipose MSC Therapy for Type 2 Diabetes
Genetically engineered adipose MSCs co-express GLP1 and FGF21, targeting islet β-cell repair. For moderate-to-severe patients inadequately controlled on triple therapy including insulin. Ages 18-70.
Umbilical Cord MSC for Knee Osteoarthritis
UC-MSC intra-articular injection suppresses synovial inflammation and promotes cartilage repair. Minimally invasive, safe, no surgery required.
Umbilical Cord MSC for Premature Ovarian Insufficiency
UC-MSC IV infusion improves ovarian microenvironment via paracrine effects, promoting follicle development and hormone restoration.
Cancer Immunotherapy
Anti-EBV Cell Vaccine Therapy
For chronic active EBV infection (EBV-DNA >50 copies/mL). DCs loaded with EBV antigens are reinfused to activate specific antiviral immunity.
EBV-Associated Hematologic Tumor DC Vaccine (Non-GMO)
Autologous DCs loaded with EBV tumor antigens for precision anti-tumor immune activation. Targets EBV-associated lymphomas and other hematologic cancers.
Why Choose Ruijin Hospital Hainan
Century-Old Ruijin Brand
Ruijin Hospital ranks among China's top 5, with #1 endocrinology nationally. A century-old brand guarantees medical quality and academic excellence.
Most Translational Projects
10 approved projects across 5 major fields—respiratory, neurology, ophthalmology, metabolism, and oncology—making it Lecheng's most active hospital.
Transparent Pricing
All projects are publicly registered and priced by the Lecheng Administration, from ¥16K to ¥480K, allowing clear cost planning in advance.
Interested in Advanced Treatments at Ruijin Hainan?
Our medical advisors will help assess your eligibility and connect you with Ruijin's expert team.
Book a Consultation